tiprankstipranks
OSE Immunotherapeutics SA (DE:6OP)
FRANKFURT:6OP
Germany Market
6OP
OSE Immunotherapeutics SA
RESEARCH TOOLSreports

OSE Immunotherapeutics SA (6OP) Income Statement

1 Followers

OSE Immunotherapeutics SA Income Statement

Last quarter (Q4 2025), OSE Immunotherapeutics SA's total revenue was €1.30M, an increase of 49.14% from the same quarter last year. In Q4, OSE Immunotherapeutics SA's net income was €-22.59M. See OSE Immunotherapeutics SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 2.62M€ 69.88M€ 2.23M€ 18.30M€ 26.31M
Gross Profit
€ 0.00€ 69.88M€ 2.23M€ 18.30M€ 26.31M
Operating Expenses
€ 44.60M€ 41.52M€ 25.21M€ 36.78M€ 42.93M
Depreciation and Amortization
€ 3.25M€ 3.36M€ 3.52M€ 3.56M€ 2.66M
EBITDA
€ -44.81M€ 41.20M€ -17.50M€ -13.11M€ -13.72M
Operating Income
€ -48.06M€ 43.73M€ -22.99M€ -18.48M€ -16.63M
Other Income/Expenses
€ 6.00M€ -3.90M€ -235.00K€ 454.00K€ -588.00K
Pretax Income
€ -42.05M€ 39.83M€ -23.22M€ -23.45M€ -21.56M
Net Income
€ -37.70M€ 37.45M€ -23.00M€ -17.76M€ -16.85M
Per Share Metrics
Basic EPS
€ -1.69€ 1.72€ -1.18€ -0.96€ -0.93
Diluted EPS
€ -1.69€ 1.72€ -1.18€ -0.96€ -0.93
Weighted Average Shares Outstanding
 22.31M 21.81M 19.56M 18.46M 18.16M
Weighted Average Shares Outstanding (Diluted)
 22.31M 21.81M 19.56M 18.46M 18.16M
Currency in EUR

OSE Immunotherapeutics SA Earnings and Revenue History